Written and maintained by CASRAI Editorial Board
Published
On this page
Circulation: Heart Failure is a peer-reviewed monthly medical journal published online by Wolters Kluwer on behalf of the American Heart Association (AHA). Established in May 2008 as a dedicated subspecialty offshoot of the flagship journal Circulation, the publication focuses on basic, translational, clinical, and outcomes research concerning heart failure, cardiomyopathies, mechanical circulatory support, and heart transplantation. Operating under a hybrid open-access model, the journal maintains a 2024 Journal Impact Factor of 8.3 and is indexed across major bibliographic databases including MEDLINE, PubMed, and Web of Science.
What is Circulation: Heart Failure?
Circulation: Heart Failure is an official peer-reviewed scientific journal in the American Heart Association portfolio. It was founded in 2008 to provide specialized coverage of myocardial disease, advanced hemodynamics, and circulatory assist technology as heart failure management evolved into a distinct cardiovascular subspecialty. While the flagship Circulation journal covers broad cardiovascular medicine spanning vascular biology, interventional cardiology, electrophysiology, and preventive medicine, Circulation: Heart Failure dedicates its entire editorial footprint exclusively to myocardial dysfunction, circulatory support, and heart failure clinical trials.
The journal launched with Volume 1, Number 1 in May 2008 under the imprint of Lippincott Williams and Wilkins (now Wolters Kluwer Health). It originally appeared in both print and electronic formats, carrying Print ISSN 1941-3289 and Online ISSN 1941-3297. As biomedical publishing transitioned to rapid electronic dissemination, print issues ceased with Volume 5, Number 6 in late 2012, establishing Circulation: Heart Failure as an online-only electronic serial. Searchers frequently distinguish this title from unrelated publications, such as the Japanese Circulation Society’s official publication, Circulation Journal, or broad general cardiology periodicals. Circulation: Heart Failure functions specifically as the AHA’s primary forum for clinical trials, mechanistic studies, and therapeutic statements regarding acute, chronic, and advanced heart failure.
Who runs it and what it covers: Editorial Governance and Scope
Editorial direction of Circulation: Heart Failure is led by Editor-in-Chief Dr. Nancy K. Sweitzer, MD, PhD, supported by an international board of associate editors, guest editors, and biostatistical consultants from academic medical centers. Governance is provided by the American Heart Association in collaboration with its Council on Clinical Cardiology, Council on Basic Cardiovascular Sciences, and Council on Genomic and Precision Medicine, with production handled by Wolters Kluwer.
The journal covers the complete spectrum of heart failure pathophysiology, diagnostics, and patient care. Core thematic areas include:
- Clinical Trials and Registries: Randomized phase II through phase IV trials assessing pharmacological agents, neurohormonal modulators, and device interventions across heart failure with reduced (HFrEF), mildly reduced (HFmrEF), and preserved (HFpEF) ejection fraction.
- Cardiomyopathies and Genetics: Research on molecular mechanisms and clinical care for hypertrophic, dilated, and arrhythmogenic right ventricular cardiomyopathies, cardiac amyloidosis (AL and ATTR), inflammatory myocarditis, and metabolic heart diseases.
- Mechanical Circulatory Support: Studies examining durable left ventricular assist devices (LVADs), biventricular assist systems (BiVADs), temporary percutaneous pumps, extracorporeal membrane oxygenation (ECMO), total artificial hearts, and device-related hemocompatibility adverse events.
- Heart Transplantation: Science addressing donor organ preservation, recipient selection, novel immunosuppression regimens, cellular and antibody-mediated allograft rejection, allograft vasculopathy, and organ allocation policy.
- Cardiogenic Shock and Acute Failure: Hemodynamic monitoring algorithms, shock team protocols, and escalation pathways in acute decompensated heart failure and refractory cardiogenic shock.
- Cardiorenal and CKM Syndromes: Organ crosstalk mechanisms, renal hemodynamics, diuretic resistance, cardiorenal syndrome, and cardiovascular-kidney-metabolic (CKM) syndrome interventions.
- Biomarkers and Diagnostics: Circulating biomarkers including natriuretic peptides, cardiac troponins, soluble ST2, and galectin-3, alongside advanced cardiac magnetic resonance imaging and echocardiography.
- Quality of Care and Patient Outcomes: Health equity, disparities in trial enrollment, healthcare delivery, and health-related quality of life outcomes measured through instruments such as the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Journal Metrics and Indexing: Impact Factor, Scopus, and NLM Records
Quantitative bibliometrics establish Circulation: Heart Failure as a premier international venue for heart failure research. In Clarivate’s annual Journal Citation Reports, the journal holds a 2024 journal impact factor of 8.3, consistently placing it in the first quartile (Q1) within the Cardiac and Cardiovascular Systems category. This metric reflects extensive citation by clinical trialists, translational researchers, and clinical guideline panels.
Circulation: Heart Failure is indexed and preserved across premier biomedical abstracting repositories:
- U.S. National Library of Medicine: Cataloged under NLM ID 101479941 with the official Medline title abbreviation Circ Heart Fail. The journal maintains continuous, fully indexed status in MEDLINE and PubMed from its 2008 inaugural volume to the present.
- Clarivate Web of Science: Indexed in the Science Citation Index Expanded (SCIE), Current Contents/Clinical Medicine, and Journal Citation Reports.
- Elsevier Scopus and EMBASE: Tracked continuously for CiteScore, Source Normalized Impact per Paper (SNIP), and SCImago Journal Rank (SJR).
- Additional Databases: Indexed in EBSCOhost, CINAHL, ProQuest, and Google Scholar.
Publishing Model, Open Access Options, and APC Structure
Circulation: Heart Failure operates as a hybrid open access journal model. Corresponding authors whose papers are accepted can choose between traditional subscription publishing and gold open access. Under the subscription route, authors transfer publishing rights to the American Heart Association at zero author-facing cost. These articles are available to subscribers, member institutions, and individual purchasers.
Authors who choose gold open access make their final Version of Record openly available immediately under Creative Commons licenses, primarily CC-BY (Attribution) or CC-BY-NC-ND (Attribution-NonCommercial-NoDerivatives). Authors supported by funders mandating immediate public access—including the National Institutes of Health (NIH), UK Research and Innovation (UKRI), and the Wellcome Trust—can select CC-BY to maintain full policy compliance.
The standard list article processing charge (APC) for hybrid open access in Circulation: Heart Failure is approximately $5,400. Substantial discounts apply for active AHA professional members. Furthermore, Wolters Kluwer and the AHA participate in institutional Read and Publish transformative agreements that cover open access fees for affiliated researchers. For authors in low-income and lower-middle-income economies, the journal provides waivers and discounts under Research4Life eligibility guidelines.
How to Search and Access Content on the AHA Journals Platform
Circulation: Heart Failure is hosted digitally on the central American Heart Association platform powered by Wolters Kluwer at ahajournals.org. Clinicians and researchers navigate content through the following step-by-step workflow:
- Navigate to Journal Home: Visit ahajournals.org/journal/circheartfailure to review current issue contents, Ahead-of-Print articles, most read papers, and featured collections.
- Perform a Basic Keyword Search: Enter clinical terms, author names, or boolean operators (AND, OR, NOT) into the primary search bar in the site header. Enclosing terms in quotes (e.g., “cardiogenic shock” or “cardiac amyloidosis”) isolates exact phrase matches.
- Open Advanced Search: Select “Advanced Search” next to the search box to focus queries specifically within Circulation: Heart Failure or across all eleven AHA journals, restricting parameters by Title, Abstract, Author, or Digital Object Identifier (DOI).
- Filter Results: Use facet filters on the results screen to narrow records by publication date (such as past 1 year, past 5 years, or custom dates) and manuscript category (Original Research, Contemporary Review, or Research Letter).
- Access Topic Collections: Select “Collections” from the journal menu to browse thematic article groupings, including “Mechanical Circulatory Support”, “Cardiomyopathy”, and “Critical Care Cardiology”.
- View Article Assets: Open articles in full-text HTML with expandable high-resolution figures, download complete PDF files, export slide decks, and access supplemental trial protocols.
- Export Citations: Use the “Export Citation” feature on any article page to generate formatted citation files in RIS, BibTeX, or RefMan formats for import into EndNote, Zotero, or Mendeley.
- Configure Content Alerts: Register on the AHA platform to set up electronic Table of Contents (e-TOC) notifications, citation tracking alerts, or RSS feeds for immediate notice of newly published studies.
Institutional access is authenticated via IP recognition, Shibboleth, or OpenAthens single sign-on, granting university and hospital library patrons access to subscription-access articles.
Author Manuscript Submission Workflow and Formatting Guidelines
Manuscript submissions to Circulation: Heart Failure follow strict technical and ethical specifications governed by the AHA Editorial Office and the International Committee of Medical Journal Editors (ICMJE). Submissions are processed through the Editorial Manager portal:
- Select Submission Type: Authors choose the appropriate category, including Original Research, Contemporary Review, Brief Report, Research Letter, In Depth Review, Editorial, or Correspondence.
- Adhere to Article Limits: For Original Research manuscripts, authors must follow structural caps:
- Word Count: Maximum 4,000 words for the main body text, excluding title page, abstract, references, tables, and figure legends.
- Structured Abstract: Maximum 300 words organized under four mandatory headings: Background, Methods, Results, and Conclusions.
- Clinical Perspectives: A mandatory section placed immediately below the abstract containing two subsections: “What is new?” (1 to 3 concise bullet points) and “What are the clinical implications?” (1 to 3 practice-oriented bullet points).
- Display Items: Maximum combined total of 8 figures and tables. Tables must be supplied as editable text rather than graphic files.
- References: Maximum of 50 references cited numerically in AMA/NLM format.
- Apply Reporting Standards: Authors must align reporting with EQUATOR Network standards: CONSORT for randomized trials, STROBE for observational studies, PRISMA for systematic reviews, and ARRIVE for preclinical animal research.
- Verify Trial Registration: Clinical trials must be registered prospectively in a WHO-recognized public registry (such as ClinicalTrials.gov) prior to first patient enrollment, with registration details stated in the abstract.
- Disclose Preprint Postings: Prior posting on recognized preprint servers (such as medRxiv or bioRxiv) is permitted and must be declared in the cover letter with repository DOI links.
- Submit Conflict of Interest Forms: All co-authors must complete ICMJE disclosure declarations. Human studies must document institutional review board approval and participant informed consent.
- Upload Submission Files: In Editorial Manager, upload the main manuscript document (Microsoft Word), high-resolution figures (TIFF, EPS, or high-quality PDF at 300 dpi minimum), supplemental appendices, and cover letter, providing ORCID identifiers for all authors.
- Approve PDF Proof: Examine the system-generated PDF proof for formatting and figure clarity. Final author approval triggers editorial triage and assignment for single-anonymized peer review by expert clinical reviewers and statistical editors.
Strengths and Limits of Circulation: Heart Failure
Researchers weighing Circulation: Heart Failure against peer journals should evaluate its core operational strengths and structural boundaries:
Journal Strengths
- Societal Prestige: Sponsored by the American Heart Association, the journal carries high clinical credibility and routinely shapes consensus statements and international clinical guidelines.
- Focused Specialist Audience: The journal reaches an audience centered exclusively on heart failure cardiologists, transplant surgeons, and cardiovascular researchers.
- Biostatistical Rigor: Routine statistical review ensures high reproducibility and rigorous reporting of survival curves, multivariable models, and competing risks.
- Rapid Online Publication: Ahead-of-Print publishing ensures accepted manuscripts receive immediate DOI registration and PubMed visibility prior to issue compilation.
- Preprint Integration: Direct transfer mechanisms with platforms like medRxiv facilitate streamlined submission workflows.
Journal Limitations
- High Rejection Rate: Strong selectivity leads to a high rejection rate for unsolicited manuscripts without external review or following peer referee reports.
- Substantial Open Access Costs: The hybrid APC of roughly $5,400 represents a notable expense for non-funded authors whose institutions lack transformative agreements.
- Digital-Only Distribution: The discontinuation of print publication in 2012 means all distribution is exclusively digital.
- Controlled Issue Size: Publishing twelve regular monthly issues caps the annual volume of accepted original papers compared to large open-access mega-journals.
Heart Failure Specialty Journals Comparison and Alternatives
Authors considering Circulation: Heart Failure can compare its editorial scope and publishing profile with several leading cardiovascular venues dedicated to heart failure. The comparison below reviews these options:
| Journal Title | Affiliated Society | Publisher | Primary Focus | Review Model |
|---|---|---|---|---|
| Circulation: Heart Failure | American Heart Association (AHA) | Wolters Kluwer | Translational pathophysiology, clinical trials, MCS devices, transplant medicine, and patient outcomes | Single-anonymized peer review |
| JACC: Heart Failure | American College of Cardiology (ACC) | Elsevier | Clinical trials, advanced therapeutics, imaging modalities, and clinical practice algorithms | Single-anonymized peer review |
| European Journal of Heart Failure | Heart Failure Association (ESC) | Wiley | European clinical trials, registries, ESC guideline implementation, and epidemiology | Single-anonymized peer review |
| Journal of Cardiac Failure | Heart Failure Society of America (HFSA) | Elsevier | Multidisciplinary care, nursing science, health equity, patient perspectives, and clinical therapy | Single-anonymized peer review |
| ESC Heart Failure | European Society of Cardiology (ESC) | Wiley | International clinical observational studies, case series, and translational reports (Gold OA) | Single-anonymized peer review |
For detailed comparative metrics including impact factors, publication frequencies, and NLM identifiers across these titles, review the structured data table below.
Frequently asked questions
What is the Impact Factor of Circulation: Heart Failure?
According to the 2024 Clarivate Journal Citation Reports, Circulation: Heart Failure holds a Journal Impact Factor of 8.3. This metric places the journal in the first quartile (Q1) among international periodicals in the Cardiac and Cardiovascular Systems category.
Who publishes Circulation: Heart Failure?
Circulation: Heart Failure is published by Wolters Kluwer Health under the Lippincott Williams and Wilkins imprint on behalf of the American Heart Association (AHA), with editorial leadership directed by Editor-in-Chief Dr. Nancy K. Sweitzer.
Is Circulation: Heart Failure indexed in PubMed and MEDLINE?
Yes. Circulation: Heart Failure is indexed in MEDLINE, PubMed, the Web of Science Science Citation Index Expanded, and Scopus. Its NLM Unique ID is 101479941, and its cataloged Medline abbreviation is Circ Heart Fail.
What is the acceptance rate and review timeline for Circulation: Heart Failure?
Circulation: Heart Failure is a selective journal with an acceptance rate typically between 10% and 15% for unsolicited original research. Initial triage decisions occur within 1 to 2 weeks, while manuscripts sent for external peer review receive referee decisions within 4 to 6 weeks.
Does Circulation: Heart Failure offer open access publishing?
Yes. Circulation: Heart Failure is a hybrid journal. Authors can publish without author fees under subscription access or select gold open access under Creative Commons licenses (CC-BY or CC-BY-NC-ND) by paying an APC of approximately $5,400 or using institutional transformative agreements.
What article types does Circulation: Heart Failure accept?
The journal accepts Original Research, Contemporary Reviews, In Depth Reviews, Brief Reports, Research Letters, Editorials, and Correspondence. Original research papers are limited to 4,000 words, a 300-word structured abstract, a Clinical Perspectives section, 50 references, and 8 display items.
Sources
- U.S. National Library of Medicine. NLM Catalog: Circulation. Heart failure. NLM ID 101479941. https://www.ncbi.nlm.nih.gov/nlmcatalog/101479941 (accessed 2026-11-15).
- American Heart Association and Wolters Kluwer. Circulation: Heart Failure: About the Journal. https://www.ahajournals.org/journal/circheartfailure (accessed 2026-11-15).
- American Heart Association and Wolters Kluwer. Instructions for Authors: Circulation: Heart Failure. https://www.ahajournals.org/circheartfailure/author-instructions (accessed 2026-11-15).
- Clarivate. Journal Citation Reports: Circulation: Heart Failure (2024 JIF 8.3). https://jcr.clarivate.com/ (accessed 2026-11-15).
- U.S. National Library of Medicine. NLM Catalog: JACC. Heart failure. NLM ID 101598241. https://www.ncbi.nlm.nih.gov/nlmcatalog/101598241 (accessed 2026-11-15).
- U.S. National Library of Medicine. NLM Catalog: European journal of heart failure. NLM ID 100887595. https://www.ncbi.nlm.nih.gov/nlmcatalog/100887595 (accessed 2026-11-15).
- U.S. National Library of Medicine. NLM Catalog: Journal of cardiac failure. NLM ID 9442138. https://www.ncbi.nlm.nih.gov/nlmcatalog/9442138 (accessed 2026-11-15).
- American Heart Association. Open Access Information and Policy Guidelines. https://www.ahajournals.org/open-access (accessed 2026-11-15).
Data: Major Specialty Heart Failure Journals: Editorial, Metrics, and Publishing Profile Comparison
Comparative dataset analyzing premier peer-reviewed heart failure journals across sponsoring professional societies, publishing houses, Journal Impact Factors, open access models, publication frequency, and electronic indexing identifiers. Compiled from the U.S. National Library of Medicine NLM Catalog, publisher specifications, and Journal Citation Reports.
Period covered: 2008/2026. Coverage: Global.
| Journal Title | Sponsoring Society | Publisher | Journal Impact Factor (JIF) | Publishing Model | Publication Frequency (issues/year) | NLM Unique ID | Electronic ISSN |
|---|---|---|---|---|---|---|---|
| Circulation: Heart Failure | American Heart Association | Wolters Kluwer | 8.3 | Hybrid Open Access | 12 | 101479941 | 1941-3297 |
| JACC: Heart Failure | American College of Cardiology | Elsevier | 11.9 | Hybrid Open Access | 12 | 101598241 | 2213-1787 |
| European Journal of Heart Failure | Heart Failure Association (ESC) | Wiley | 10.3 | Hybrid Open Access | 12 | 100887595 | 1879-0844 |
| Journal of Cardiac Failure | Heart Failure Society of America | Elsevier | 9.9 | Hybrid Open Access | 12 | 9442138 | 1532-8414 |
Sources
- Circulation. Heart failure - NLM Catalog (accessed 2026-11-15)
- Circulation: Heart Failure - About the Journal (AHA Journals / Wolters Kluwer) (accessed 2026-11-15)
- JACC: Heart Failure - NLM Catalog (accessed 2026-11-15)
- European Journal of Heart Failure - NLM Catalog (accessed 2026-11-15)
- Journal of Cardiac Failure - NLM Catalog (accessed 2026-11-15)
- Clarivate Journal Citation Reports (accessed 2026-11-15)
Compiled by CASRAI from the sources above. Free to reuse under CC BY 4.0 with attribution.







